ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that its first ZAP-X® ...

The fourth International Conference on Advances in Radiation Oncology (ICARO-4) is underway this week at the IAEA headquarters in Vienna, bringing together participants from around the world to ...

The PSA progression free survival in Arm A was 2.6 months versus 2.5 months in Arm B, and radiologic progression free survival was 2.1 months and 1.9 months in arm A and B, respectively. The median ...

The biological equivalence of these scenarios remains uncertain, raising critical questions about treatment optimization. With advancements in planning, delivery, and imaging, stereotactic ablative ...

SRT, stereotactic radiotherapy; ICIs, immune checkpoint inhibitors; CT, chemotherapy; OS, overall survival; iPFS, intracranial progression free survival; PFS, progression free survival; iORR, ...

NHS workforce shortages threaten to undermine the rollout of new radiotherapy machines and their potential to cut waiting ...

For nearly 50 years, McLeod has been accredited by the Commission on Cancer of the American College of Surgeons. Photo ...

Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with ...

Nivolumab plus ipilimumab showed activity in mCRPC, and while adding SBRT was safe, it did not boost efficacy in the CheckPRO trial.

Helena Yu, MD, discusses the efficacy of zipalertinib for EGFR-mutant non–small cell lung cancer and the importance of exploring therapies with CNS penetration in this space.

The fourth International Conference on Advances in Radiation Oncology (ICARO-4) is underway this week at the IAEA headquarters in Vienna, bringing ...

AMT-130 has been granted the FDA’s Regenerative Medicine Advance Therapy (RMAT) designation and Breakthrough Therapy designation, the first therapy for Huntington’s disease to receive an RMAT ...